| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 7.9% | +38% | $288,079 | +$97,981 | 48,827 | +52% | Stonepine Capital Management, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 9 institutional investors reported holding 124,237 shares of CNS Pharmaceuticals, Inc. - Common Stock (CNSP). This represents 20% of the company’s total 618,063 outstanding shares.
The largest institutional shareholders of CNS Pharmaceuticals, Inc. - Common Stock (CNSP) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 7.9% | 48,827 | 0.2% | $256,342 | |
| Ikarian Capital, LLC | 7.4% | 45,830 | 0.03% | $240,608 | |
| DRW Securities, LLC | 2.5% | 15,429 | +9.8% | 0.01% | $81,002 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.2% | 13,524 | 0% | $71,001 | |
| UBS Group AG | 0.1% | 611 | -94% | 0% | $3,208 |
| BARRETT & COMPANY, INC. | 0% | 8 | 0% | 0% | $42 |
| BANK OF AMERICA CORP /DE/ | 0% | 4 | 0% | 0% | $21 |
| MAI Capital Management | 0% | 3 | 0% | 0% | $16 |
| DANSKE BANK A/S | 0% | 1 | 0% | 0% | $5 |
| CITIGROUP INC | 0% | 0 | -100% | $0 | |
| MORGAN STANLEY | 0% | 0 | -100% | $0 |